ENDO ONE pitches full-face fine line reduction for aesthetic clinics

ENDO ONE SRL is promoting its ENDO ONE diode endolaser platform for treating fine lines, facial laxity and skin remodeling in medical aesthetics. The company says the system uses ultra-fine bare-tip fibers and patient-specific protocols to target the dermis while minimizing epidermal heat injury.

Why it matters: - Aesthetic practices are looking for treatments that smooth fine lines without changing facial expression or adding artificial volume. - ENDO ONE SRL is positioning its platform as a way to treat both superficial rhytids and deeper dermal micro-laxity in one procedure. - The company says the approach is designed for delicate zones such as the lips, eyes and cheeks, where standard surface treatments can be limited.

What happened: - ENDO ONE SRL unveiled its ENDO ONE diode endolaser platform for clinical fine line reduction in medical aesthetics. - The system uses ultra-fine bare-tip optical fibers placed in the superficial subdermal plane to deliver photothermal energy to the reticular dermis. - The company says the treatment is intended to stimulate immediate collagen contraction and longer-term neocollagenesis. - The announcement was made from Pozzuoli, Italy, with a web link to the company's announcement.

The details: - The platform uses 400 micrometer bare-tip fibers to navigate the dermal-subdermal junction with minimal tissue displacement. - A 20-gauge puncture portal is used for fiber entry, with placement along natural margins such as the pre-auricular crease or vermilion border. - The system includes a 650 nanometer red aiming beam to confirm fiber position through transillumination. - Pulse durations and intervals can be adjusted from 0.1 milliseconds to 10,000 milliseconds. - The company says pulse settings of 10 to 50 milliseconds, paired with equal cooling intervals, heat collagen to 60 to 65 degrees Celsius. - Real-time non-contact thermal monitoring is used to keep epidermal temperature below 40 to 42 degrees Celsius. - For lower cheeks with fine static rhytids and mild superficial adiposity, the company recommends blended 980 nanometer and 1470 nanometer wavelengths. - For atrophic dermal thinning around the eyes and mouth, the company says clinicians can use 1470 nanometer energy alone at 2 to 4 watts. - The treatment is described as a standalone regenerative procedure that can be followed weeks later by superficial non-ablative resurfacing or chemical exfoliation.

Between the lines: - The release frames fine line treatment as a structural dermal problem, not just a surface texture issue. - That positioning matters because it supports a pitch for deeper remodeling while arguing for less epidermal injury than transcutaneous laser approaches. - ENDO ONE SRL is also trying to differentiate the platform through individualized protocols rather than a one-size-fits-all aesthetic workflow.

What's next: - ENDO ONE SRL says medical directors and proceduralists can contact advisory specialists for protocol documentation, fiber selection guidance and implementation support. - The company is steering interested practices to its website for system specifications and consultation requests.

The bottom line: - ENDO ONE SRL is marketing its endolaser platform as a precision alternative for clinics that want deeper facial rejuvenation with customizable energy delivery and minimal downtime.